Search - tctmd.com

Displaying 21 - 40 of 115

Sort: Relevancy | Date

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

Presentation NY Valves 2024

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Lessons From the Initial FDA Trials

Presenter: David J. Cohen

June 06, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Advertisement

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

What’s Going to Be Big at TCT 2024?

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for June 2024

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Lessons From the Initial FDA Trials

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

FDA Approves TriClip TEER Device for Tricuspid Repair

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Debating the Role of T-TEER in the Sickest Patients

TCTMD’s Top 10 Most Popular Stories for February 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

TCTMD’s Top 10 Most Popular Stories for October 2023

What’s Going to Be Hot at TCT 2023

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content